Abstract: A sustained-release formulation includes, based on the total weight of the sustained-release formulation, 25.00 wt % to 31.25 wt % of an active pharmaceutical ingredient (API) including an acetone-extracted product of gamboge resin, 4 wt % to 25 wt % of sodium lauryl sulfate (SLS), 15.63 wt % to 23.44 wt % of hydroxypropyl methylcellulose, 6.25 wt % to 13.38 wt % of microcrystalline cellulose, 0.63 wt % to 1.56 wt % of silicon dioxide, 0.63 wt % to 1.56 wt % of magnesium stearate, 25.00 wt % to 40.13 wt % of lactose, and 5.00 wt % to 7.81 wt % of dextrose.

Abstract: Disclosed herein is a pharmaceutical composition that includes, based on the total weight of the composition, 5% to 30% of an active pharmaceutical ingredient including an acetone-extracted product and a saccharide compound in a weight ratio of 9:1, 20% to 75% of a solubilizing agent, 5% to 30% of a disintegrating agent, 5% to 30% of a filling agent, 0.1% to 5% of a flow agent, and 0.1% to 5% of a lubricant. The active pharmaceutical ingredient has an average particle size of about 1 ?m to 30 ?m.

Abstract: Disclosed herein are seventeen new compounds obtained from an acetone-extracted product of gamboge resin. The seventeen new compounds have activities in inhibiting the growth of tumor/cancer cells.

Abstract: Disclosed herein are seventeen new compounds obtained from an acetone-extracted product of gamboge resin. The seventeen new compounds have activities in inhibiting the growth of tumor/cancer cells.

Abstract: Disclosed herein are seventeen new compounds and five fractionated products obtained from an acetone-extracted product of gamboge resin. The seventeen new compounds and the five fractionated products have activities in inhibiting the growth of tumor/cancer cells. In addition, the acetone-extracted product of gamboge resin and the five fractionated products obtained therefrom have analgesic and anti-inflammatory effects.

Abstract: Disclosed herein are seventeen new compounds and five fractionated products obtained from an acetone-extracted product of gamboge resin. The seventeen new compounds and the five fractionated products have activities in inhibiting the growth of tumor/cancer cells. In addition, the acetone-extracted product of gamboge resin and the five fractionated products obtained therefrom have analgesic and anti-inflammatory effects.

Abstract: Disclosed herein are seventeen new compounds obtained from an acetone-extracted product of gamboge resin. The seventeen new compounds have activities in inhibiting the growth of tumor/cancer cells.

Abstract: Disclosed herein are an acetone-extracted product obtained from gamboge resin and compounds further purified from said acetone-extracted product, including a new compound called formoxanthone A. The acetone-extracted product and the further purified compounds have been demonstrated to have activities in inhibiting the growth of tumor/cancer cells. Also disclosed are the processes for obtaining said further purified compounds, and the uses of the acetone-extracted product and the further purified compounds in the preparation of pharmaceutical composition for inhibiting the growth of tumor/cancer cells.

Abstract: Disclosed herein are an acetone-extracted product obtained from gamboge resin and compounds further purified from said acetone-extracted product, including a new compound called formoxanthone A. The acetone-extracted product and the further purified compounds have been demonstrated to have activities in inhibiting the growth of tumor/cancer cells. Also disclosed are the processes for obtaining said further purified compounds, and the uses of the acetone-extracted product and the further purified compounds in the preparation of pharmaceutical composition for inhibiting the growth of tumor/cancer cells.